Publicaciones en colaboración con investigadores/as de University of Texas Southwestern Medical Center (3)

2021

  1. Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension

    JACC: Basic to Translational Science, Vol. 6, Núm. 1, pp. 12-21

2005

  1. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: Results from the Dallas Heart Study

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 25, Núm. 10, pp. 2192-2196

2003

  1. Soluble CD40L: Risk prediction after acute coronary syndromes

    Circulation, Vol. 108, Núm. 9, pp. 1049-1052